A Pharmacokinetic Study of Trabectedin in Patients With Advanced Malignancies and Hepatic Dysfunction
Status:
Completed
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to characterize the pharmacokinetics (blood levels) of
trabectedin after administration to patients with advanced malignancies and hepatic (liver)
dysfunction.